prof. dr. E. Hak
Full professor of Clinical Pharmacoepidemiology
Prof. Hak (1968) studied Biomedical Health Sciences in Nijmegen and Health Education in Wageningen, and specialized as an epidemiologist/methodologist. He performed his clinical epidemiological PhD studies at the Julius Center for Health Care at the University Medical Center Utrecht (former head prof Grobbee) and followed post-doctoral courses at the Boston University, University of Baltimore and Erasmus University Rotterdam to become a senior (clinical) epidemiologist registered by the Netherlands Society for Epidemiology in 2001. After visiting professorships in Minneapolis (USA) he became a NWO-VENI laureate in 2005 and was promoted associate professor of clinical epidemiology at the UMC Utrecht in 2007 and later in 2009 at the department of epidemiology, UMC Groningen (current head Prof Boezen).
As of June 2010 he was appointed tenure track professor of clinical pharmacoepidemiology at the Groningen Research Institute of Pharmacy (GRIP, head Prof Frijlink). In 2015 he was promoted full professor of clinical pharmacoepidemiology to head the pharmacoepidemiology research and education within GRIP. He is also affiliated with the Epidemiology department, University Medical Center Groningen, and performed two visiting professorships (Universities Boston and Ghent).
In 2017 he was (co-)author of more than 300 peer-reviewed papers (Web of Science: H-index 36, average citation 16, total 5,300 citations) among which top publications appeared in New England Journal of Medicine, JAMA, Annals of Internal Medicine, Lancet Infectious Diseases, Lancet Respiratory Medicine, Archives of Internal Medicine, JACI and BMJ. He (co-)supervised 18 PhD research fellows who obtained their doctorate and 10 PhD fellows are currenty in their PhD trajectory. He is chair of the in-house pharmacy prescription database IADB.nl covering detailed anonymous prescription data of more than 1.2 million persons which can be linked to various external databases through Statistics Netherlands (e.g. Lifelines cohort as of first quarter 2018).
Prof Hak has a broad interest in interdisciplinary research on efficacy (premarketing) versus effect (postmarketing) studies using meta-analytical techniques and Individual Patient Databases, novel design and statistical methodologies to deal with confounding in real-world intervention research, in combining epidemiological and economical data in HTA modeling as well as preventive drug/vaccine implementation research.
He is currently (co-)chair of the GUIDE graduate school research group Real-world data research in Pharmaco-Epidemiology, -Genetics, -Economics &- Therapy (PEGET), deputy director of the Master of Pharmaceutical Sciences (MPS), coordinator of the speciality track "Pharmacoepidemiology" of the MPS (see also www.pharmaceutical tracks.com), working package leader Clinical trial program with universal flu vaccines of the FP-7 project UNISEC (see http://www.unisecconsortium.eu/) and member of the Ethics committee BEBO in Assen. He has been a member of the Dutch Health Council Committee on Vaccination since 2007. He was elected member of the Faculty Council FMNS in 2015 and 2017. Since mid 2009 he has been director of a consultancy acknowledged by ZONMW to coach health care researchers, both from academia and other non-profit health care organizations (www.epicoach.nl VOF).
|Last modified:||13 February 2018 3.57 p.m.|